WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating
WNT signaling activates MYC expression in cancer cells. Here we report that this involves an oncogenic super-enhancer-mediated tethering of active MYC alleles to nuclear pores to increase transcript export rates. As the decay of MYC transcripts is more rapid in the nucleus than in the cytoplasm, the...
Saved in:
Published in | Nature genetics Vol. 51; no. 12; pp. 1723 - 1731 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.12.2019
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | WNT signaling activates
MYC
expression in cancer cells. Here we report that this involves an oncogenic super-enhancer-mediated tethering of active
MYC
alleles to nuclear pores to increase transcript export rates. As the decay of
MYC
transcripts is more rapid in the nucleus than in the cytoplasm, the oncogenic super-enhancer-facilitated export of nuclear
MYC
transcripts expedites their escape from the nuclear degradation system in colon cancer cells. The net sum of this process, as supported by computer modeling, is greater cytoplasmic
MYC
messenger RNA levels in colon cancer cells than in wild type cells. The cancer-cell-specific gating of
MYC
is regulated by AHCTF1 (also known as ELYS), which connects nucleoporins to the oncogenic super-enhancer via β-catenin. We conclude that WNT signaling collaborates with chromatin architecture to post-transcriptionally dysregulate the expression of a canonical cancer driver.
Oncogenic
MYC
expression involves super-enhancer-mediated tethering of
MYC
alleles to nuclear pores, thus increasing messenger RNA export. This is regulated by AHCTF1 and β-catenin. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1061-4036 1546-1718 1546-1718 |
DOI: | 10.1038/s41588-019-0535-3 |